Urgent need for global action against antimicrobial resistance: Report

Even as nearly 5 million deaths are associated with Antimicrobial Resistance AMR every year worldwide a new report has called for urgent need for global actionThe 2024 AMR Preparedness Index Progress Report released by the Global Coalition on Aging and the Infectious Diseases Society of America IDSA shows that while large global economies have made some progress in their efforts to address AMR they need to do more to reduce the health and financial impactThe report assesses how the 11 largest global economies Brazil Canada China France Germany India Italy Japan South Korea the UK and the US have advanced on calls to action laid out in the 2021 AMR Preparedness IndexThe 2021 Index examined over 100 metrics to evaluate and rank countriesrsquo performance against AMR and establish benchmarks for policy action and leadershipldquoEach year nearly 5 million deaths are associated with AMR with a disproportionate impact on low and middleincome countries Without the creation of innovative and novel antimicrobials growing resistance to our existing drugs threatens our ability to perform even routine medical carerdquo the report saidldquoAMR is a significant barrier to health system sustainability and public health including healthy ageing It is also an economic challenge without correcting course on AMR the World Bank estimates that AMR could cost the global economy as much as 34 trillion annually by 2023rdquo it addedThe report showed that the UK maintained its position as the global leader in the fight against AMR and many of the countries showed promising progress in many areas but there is still greater action and targeted investment needed across all countries evaluated particularly to revive the floundering pipeline of novel antibioticsldquoAMR is no longer just a public health threat it is already hererdquo said Michael Hodin CEO of GCOA in a statement ldquoItrsquos imperative that global leaders leverage their power both separately and collaboratively to commit and implement concrete actions in the face of growing drug resistance Without such action we risk losing antibiotics and with them our ability to enjoy the longevity that we do currentlyrdquoThis story has been sourced from a third party syndicated feed agencies Midday accepts no responsibility or liability for its dependability trustworthiness reliability and data of the text Midday managementmiddaycom reserves the sole right to alter delete or remove without notice the content in its absolute discretion for any reason whatsoever